Total Payments
$7,084
2024 Payments
$730.39
Companies
33
Transactions
380
Medicare Patients
24,428
Medicare Billing
$824,870
Payment Breakdown by Category
Food & Beverage$6,701 (94.6%)
Education$382.64 (5.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,701 | 374 | 94.6% |
| Education | $382.64 | 6 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,026 | 65 | $0 (2024) |
| Astellas Pharma US Inc | $847.50 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $635.76 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $551.95 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $505.41 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $470.50 | 30 | $0 (2022) |
| Amgen Inc. | $412.94 | 19 | $0 (2021) |
| Novo Nordisk Inc | $311.18 | 21 | $0 (2022) |
| PFIZER INC. | $291.94 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $261.55 | 17 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.39 | 42 | ABBVIE INC. ($222.75) |
| 2023 | $859.66 | 49 | AbbVie Inc. ($226.20) |
| 2022 | $920.25 | 48 | ABBVIE INC. ($222.78) |
| 2021 | $1,316 | 55 | AbbVie Inc. ($222.72) |
| 2020 | $678.65 | 44 | Novo Nordisk Inc ($109.26) |
| 2019 | $1,058 | 54 | Astellas Pharma US Inc ($205.07) |
| 2018 | $697.20 | 34 | Astellas Pharma US Inc ($179.34) |
| 2017 | $823.59 | 54 | Merck Sharp & Dohme Corporation ($137.11) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Oncology | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Respiratory | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: Cardiovascular | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 5,160 | 7,472 | $942,090 | $204,481 |
| 2022 | 39 | 5,358 | 8,094 | $752,387 | $201,134 |
| 2021 | 37 | 6,579 | 9,908 | $743,566 | $213,941 |
| 2020 | 41 | 7,331 | 10,206 | $762,035 | $205,314 |
Total Patients
24,428
Total Services
35,680
Medicare Billing
$824,870
Procedure Codes
155
All Medicare Procedures & Services
155 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 299 | 509 | $209,590 | $53,607 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 193 | 343 | $99,740 | $27,135 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 180 | 180 | $110,700 | $26,682 | 24.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 139 | 196 | $51,940 | $8,632 | 16.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 361 | 651 | $40,395 | $8,517 | 21.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 113 | 113 | $31,640 | $8,491 | 26.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 369 | 683 | $29,725 | $7,061 | 23.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 342 | 546 | $84,480 | $6,949 | 8.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 324 | 398 | $30,110 | $6,537 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 365 | 718 | $23,240 | $6,023 | 25.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 248 | 251 | $39,560 | $5,984 | 15.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 31 | 36 | $20,160 | $4,892 | 24.3% |
| 92553 | Test for hearing various pitches using earphone and device placed against the bone | Office | 2023 | 123 | 124 | $26,030 | $4,828 | 18.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 349 | 607 | $20,365 | $4,614 | 22.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 115 | 116 | $10,745 | $4,174 | 38.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 323 | 398 | $17,680 | $3,511 | 19.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 129 | 154 | $13,090 | $2,775 | 21.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 234 | 279 | $12,750 | $2,656 | 20.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 35 | $6,680 | $1,836 | 27.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 37 | 37 | $26,810 | $1,800 | 6.7% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 159 | 261 | $7,500 | $1,665 | 22.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 34 | 39 | $4,410 | $1,131 | 25.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 63 | 76 | $5,320 | $1,123 | 21.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 44 | 47 | $3,290 | $677.27 | 20.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 181 | 213 | $3,195 | $659.90 | 20.7% |
About Dr. Paul Schwartz, M.D
Dr. Paul Schwartz, M.D is a Internal Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073583852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Schwartz, M.D has received a total of $7,084 in payments from pharmaceutical and medical device companies, with $730.39 received in 2024. These payments were reported across 380 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,701).
As a Medicare-enrolled provider, Schwartz has provided services to 24,428 Medicare beneficiaries, totaling 35,680 services with total Medicare billing of $824,870. Data is available for 4 years (2020–2023), covering 155 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Manhasset, NY
- Active Since 01/25/2006
- Last Updated 03/07/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073583852
Products in Payments
- UBRELVY (Drug) $547.08
- JARDIANCE (Drug) $450.03
- LEQVIO (Drug) $436.14
- ELIQUIS (Drug) $388.55
- FARXIGA (Drug) $386.29
- MYRBETRIQ (Drug) $296.04
- QULIPTA (Drug) $262.08
- Vascepa (Drug) $234.60
- JANUVIA (Drug) $208.49
- Aimovig (Biological) $181.66
- XARELTO (Drug) $172.63
- SHINGRIX (Biological) $162.04
- Ozempic (Drug) $131.30
- ASMANEX (Drug) $120.29
- NEXLETOL (Drug) $119.21
- Myrbetriq (Drug) $118.25
- ENTRESTO (Drug) $115.81
- Victoza (Drug) $115.03
- Cologuard Collection Kit (Device) $114.29
- Repatha (Biological) $114.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Manhasset
Anna Imperato, M.d, M.D
Internal Medicine — Payments: $593,858
Internal Medicine $593,858
Dr. Harmit Kalia, D.o, D.O
Internal Medicine — Payments: $45,969
Internal Medicine $45,969
Bradley Sherman, Md, MD
Internal Medicine — Payments: $31,930
Internal Medicine $31,930
Dr. Samy Selim, Md, MD
Internal Medicine — Payments: $24,755
Internal Medicine $24,755
Emad Sedki, M.d, M.D
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Suchet Kumar, M.d, M.D
Internal Medicine — Payments: $9,358
Internal Medicine $9,358